The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Location status: Recruiting
Location contact
Diane M Santa Maria, DrPH, MSN, RN, PHNA-BC, FSAHM
CONTACT
Jennifer Jones
CONTACT
NCT Number: NCT06074354
The purpose of this study is to determine whether Motivating Youth to Reduce Infections, Disconnections, and Emotion dysregulation (MY-RIDE) decreases substance use , to determine whether MY-RIDE increases human immunodeficiency virus (HIV) prevention strategies and to evaluate MY-RIDE effects on willingness to take Pre-Exposure Prophylaxis (PrEP), stress, substance use urge, and use of mental health and substance use services when compared to attention control youth
Interested in participating?
Request Info18 year–25 year
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Location status: Recruiting
Diane M Santa Maria, DrPH, MSN, RN, PHNA-BC, FSAHM
CONTACT
Jennifer Jones
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive a one-hour general health promotion session from a nurse and be issued a phone that will deploy the EMA on the same schedule as the intervention arm. They will also receive usual care from the clinics, drop-in center, and shelter recruitment sites. Usual care includes accessing social workers and case managers for immediate housing, food, and clothing needs and assistance in navigating the local Continuum of Care system to access social services.
MY-RIDE has three main components: 1) One nurse-led face-to-face session; 2) three months of Ecological Momentary Assessments (EMA) with personalized messaging delivered by phone in real-time in response to one's current risk; and 3) access to on-demand healthcare/PrEP navigation and referrals.
Time frame: baseline, end of intervention (3 months after baseline), 3 months after intervention, 6 months after intervention, and 12 months after intervention
Time frame: baseline, end of intervention (3 months after baseline), 3 months after intervention, 6 months after intervention, and 12 months after intervention
Time frame: baseline, end of intervention (3 months after baseline), 3 months after intervention, 6 months after intervention, and 12 months after intervention
PrEP uptake is defined as the self initiation of HIV prevention medication
Time frame: baseline, end of intervention (3 months after baseline), 3 months after intervention, 6 months after intervention, and 12 months after intervention
This will be assessed by a blood test to detect biomarkers for HIV and Syphilis, and urine test for Gonorrhea and Chlamydia
Contact information is provided by the study sponsor or research team.
Diane M Santa Maria, DrPH, MSN, RN, PHNA-BC, FSAHM
CONTACT
Jennifer Jones
CONTACT
The University of Texas Health Science Center, Houston
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737340
Blood-Borne Infections, Communicable Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07728123
Blood-Borne Infections, Communicable Diseases
Tampa, Florida, United States
View Trial DetailsNCT07473778
Blood-Borne Infections, Communicable Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07682961
Blood-Borne Infections, Communicable Diseases
Fort Lauderdale, Florida, United States
View Trial Details